Gar Hildenbrand Alternatives was founded by Gar Hildenbrand, known and respected for contributions in outcomes research and US federal policy regarding alternative methods of cancer management. From his critical role during the 1980s with the US Congressional Office of Technology Assessment study Unconventional Cancer Treatments (OTA H-405), Hildenbrand has been recognized as a scholarly contributor to the growing field of evaluation of the alternatives.

The Gar Hildenbrand Alternatives Cancer Treatment and Education Program (AltCTEP), however, goes beyond issues of science and evaluation to a core concern of most medical consumers: effective treatment. Over the past 15 years, we have worked to integrate two of the best documented anticancer treatments, Gerson's dietotherapy and Coley's toxins. This was an idea we got from Dr Gerson himself (see the overview section), and the integrative approach has led to remarkable improvements in overall outcomes. Recent brilliant contributions to our understanding of the immune system, especially the dendritic cell discoveries of Steinman, and the Danger Model of Matzinger and Fuchs, have given us even more tools by suggesting new ways to use existing materials. Even if you have exhausted standardized protocols, there may be viable ways forward in your battle against disease.